Related Experiment Video
Updated: Jun 4, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
Why implementing machine learning algorithms in the clinic is not a plug-and-play solution: a simulation study of a
Gernot Pucher1, Till Rostalski2, Felix Nensa3
1Department of Haematology & Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany; Laboratory for Clinical Research and Real-World Evidence, Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.
Implementing artificial intelligence (AI) for acute leukaemia diagnosis showed lower performance in real-world simulations. Local validation and recalibration are crucial for AI-PAL and similar machine learning (ML) models in clinical settings.
Area of Science:
- Medical Informatics
- Clinical Decision Support Systems
- Artificial Intelligence in Healthcare
Background:
- Artificial intelligence (AI) and machine learning (ML) show promise in clinical medicine but often lack real-world validation.
- Many published algorithms remain unvalidated in practical clinical settings, hindering widespread adoption.
- This study addresses the gap by simulating the implementation of a specific ML algorithm for acute leukaemia diagnosis.
Purpose of the Study:
- To simulate the practical implementation challenges of the AI-PAL ML algorithm for acute leukaemia diagnosis.
- To evaluate the real-world performance of AI-PAL in a clinical setting.
- To highlight the necessity of local validation and adjustments for ML algorithms in healthcare.
Main Methods:
- A detailed simulation of the AI-PAL algorithm's implementation was conducted at the University Hospital Essen.
- Cohort building utilized a Fast Healthcare Interoperability Resources (FHIR) database to identify relevant patient cases.
- Algorithm performance was assessed by reproducing prior study results and analyzing diagnostic outcomes.
Main Results:
- The AI-PAL algorithm exhibited significantly lower performance in the simulated clinical implementation compared to published results.
- Area under the ROC curve for acute lymphoblastic leukaemia was 0.67 and for acute myeloid leukaemia was 0.71.
- Recalibrating probability cutoffs increased confident acute leukaemia diagnoses from 98 to 160, indicating a need for local adjustments.
Conclusions:
- Implementing ML algorithms in clinical practice presents significant challenges.
- ML models like AI-PAL require substantial adjustments and recalibration for optimal performance in diverse clinical settings.
- Local performance validation of clinical decision support algorithms is essential before routine integration to ensure reliability and patient safety.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018